In particular, the epidermal growth factor receptor (EGFR) is known to be overexpressed in a variety of human cancer cell lines including pancreatic, breast, and colorectal cancers, and thus is an ideal marker for targeted tumor therapy [4,5]. This evidence concerns the gene EGFR and colorectal cancer.